化合物 Pimodivir tosylate T70207

Product Introduction
Bioactivity


英文名: Pimodivir tosylate

描述: Pimodivir, also known as VX-787, JNJ-872, is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. VX-787 binds the cap-binding domain of the PB2 subunit with a KD (dissociation constant) of 24 nM as determined by isothermal titration calorimetry (ITC). The cell-based EC50 (the concentration of compound that ensures 50% cell viability of an uninfected control) for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay, with a similar EC50 in a viral RNA replication assay. VX-787 is active against a diverse panel of influenza A virus strains, including H1N1pdm09 and H5N1 strains, as well as strains with reduced susceptibility to neuraminidase inhibitors (NAIs).

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: Pimodivir Tosylate | SB1B57 | SB 1B57

化合物 Pimodivir tosylate T70207信息由TargetMol中国为您提供，如您想了解更多关于化合物 Pimodivir tosylate T70207报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途